LINACTRO Trademark

Trademark Overview

On Wednesday, April 24, 2013, a trademark application was filed for LINACTRO with the United States Patent and Trademark Office. The USPTO has given the LINACTRO trademark a serial number of 79130598. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, April 23, 2023. This trademark is owned by NOVARTIS AG. The LINACTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
linactro

General Information

Serial Number79130598
Word MarkLINACTRO
Filing DateWednesday, April 24, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, April 23, 2023
Registration Number4445817
Registration DateTuesday, December 10, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, November 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, November 20, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, November 20, 2023DEATH OF INTERNATIONAL REGISTRATION
Tuesday, August 25, 2020NOTIFICATION PROCESSED BY IB
Friday, November 29, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, November 29, 2019DEATH OF INTERNATIONAL REGISTRATION
Monday, December 10, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, April 3, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 14, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 14, 2014FINAL DISPOSITION PROCESSED
Monday, March 10, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 10, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2013PUBLISHED FOR OPPOSITION
Monday, September 23, 2013NOTIFICATION PROCESSED BY IB
Wednesday, September 4, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 4, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 13, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 5, 2013ASSIGNED TO LIE
Tuesday, July 30, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 22, 2013REFUSAL PROCESSED BY IB
Tuesday, July 16, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 16, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 3, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 3, 2013REFUSAL PROCESSED BY MPU
Wednesday, July 3, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 2, 2013SUSPENSION LETTER WRITTEN
Thursday, June 27, 2013ASSIGNED TO EXAMINER
Friday, June 21, 2013APPLICATION FILING RECEIPT MAILED
Monday, June 17, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 13, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

linactro disorders system preparations pharmaceutical diseases treatment prevention caused bacteria ophthalmology